Related Experiment Video
Updated: Aug 8, 2026

In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability
Published on: October 19, 2018
IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells
Fadia R Homaidan1, Marwan E El-Sabban, Iman Chakroun
1Department of Physiology, Faculty of Medicine, American University of Beirut, Lebanon. fh01@aub.edu.lb
Insights
Interleukin-1 (IL-1) increases ceramide in inflammatory bowel disease (IBD) cells, but does not cause cell death. This suggests ceramide may contribute to increased tumor risk in IBD patients.
Area of Science:
- Gastroenterology
- Cell Biology
- Molecular Biology
Background:
- Elevated cytokine levels, including interleukin-1 (IL-1), are characteristic of inflammatory bowel disease (IBD).
- Previous research demonstrated IL-1 activates phospholipid signaling pathways in intestinal epithelial cells (IEC), leading to increased ceramide levels.
Purpose of the Study:
- To investigate whether ceramide induces apoptosis in intestinal epithelial cells (IEC).
Main Methods:
- Apoptosis was assessed using annexin-V binding and Hoechst nuclear staining.
- Western blotting was employed to quantify levels of apoptosis-related proteins (bcl-2, bcl-x, bax, p53, p21).
- Cell cycle analysis was performed using flow cytometry.
Main Results:
- Interleukin-1 (IL-1) induced a time- and concentration-dependent increase in ceramide accumulation in IEC.
- Neither IL-1 nor ceramide treatment resulted in apoptosis of IEC.
- IL-1 and ceramide modulated apoptosis-related protein expression, increasing bcl-2 and decreasing bax and p21, while bcl-x and p53 remained unchanged.
- A slight but significant increase in the G2/M phase of the cell cycle was observed.
Conclusions:
- Ceramide accumulation, induced by IL-1 in IEC, does not directly trigger apoptosis.
- The observed changes in apoptosis-related proteins and cell cycle suggest a potential role for ceramide in the enhanced tumorigenic activity observed in IBD patients.
Background:
In inflammatory bowel disease (IBD), cytokine levels (such as interleukin-1 (IL-1)) are elevated. We have shown previously that IL-1 activates phospholipid signaling pathways in intestinal epithelial cells (EEC), leading to increased ceramide levels.
Aim:
To determine whether ceramide induces apoptosis in IEC.
Methods:
Apoptosis was evaluated by annexin-V binding or Hoechst nuclear staining. Levels of bcl-2, bcl-x, bax, p53 and p21 were determined by Western blotting, and celi cycle analysis was determined by flow cytometry.
Results:
IL-1 increased ceramide accumulation in a time-dependent and concentration-dependent manner with a peak response at 4 h, with [IL-1] = 30 ng/ml. Neither IL-1 nor ceramide induced apoptosis in EEC, but they increased bcl-2 levels and decreased bax and p21 levels without affecting bcl-x and p53 levels. They also caused a slight but significant increase in the G2/M phase. These data suggest a role for ceramide in IBD and suggest a possible mechanism for the enhanced tumorigenic activity in IBD patients.
Related Concept Videos
IP3/DAG Signaling Pathway
Renewal of Intestinal Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

